Administrator Angeion Group Announces an LGBCoin, LTD Class Action

If You Bought the LetsGoBrandon Coin (“LGBCoin”), You May be a Member of a Class Action A federal court authorized this notice. This is not a solicitation from a lawyer. A class action lawsuit is pending in the United States District Court for the Middle District of Florida, Orlando Division (the “Court”) against James Koutoulas […]

Remedy Science Launches Nationally at Target, Signaling a New Era of Straightforward, Expert-Led Dermatological Skincare

The dermatologist-founded challenger brand backed by one of the largest skincare communities in the world is taking on generic formulas, over-hyped ingredients, and big beauty's complex routines; with advanced, accessible products built for real results. REMEDY, the skincare brand created by board-certified dermatologist Dr. Muneeb Shah, whose evidence-based education has earned him the trust of

INSP DEADLINE ALERT: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important January 5 Deadline in Securities Class Action – INSP

(NYSE:INSP), NEW YORK, Dec. 28, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the “Class Period”), of the important January 5, 2026 lead plaintiff deadline. SO

INSP DEADLINE ALERT: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important January 5 Deadline in Securities Class Action – INSP

INSP DEADLINE ALERT: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important January 5 Deadline in Securities Class Action – INSP GlobeNewswire December 28, 2025 NEW YORK, Dec. 28, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of

January 12, 2026 Deadline: Join Class Action Lawsuit Against Freeport-McMoRan Inc. (FCX) – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / December 28, 2025 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Freeport-McMoRan Inc. (NYSE:FCX) securities. If you suffered a loss on your Freeport-McMoRan Inc. investment and would like to explore a potential

Scroll to Top